Evidence map›Paper›PMID 42287388›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Evaluating early vs. late static SUVR windows of [¹⁸F]MK-6240 tau PET in Alzheimer disease: a head-to-head comparison study.

Tsung-Wei Hu, Jennette Prince, Liangdong Zhou, Xiuyuan Hugh Wang, Emily B Tanzi, Mohammad Khalafi, Sadek A Nehmeh, Silky Singh Pahlajani, Hani Hojjati, Lidia Glodzik and 3 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tsung-Wei HuDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.ORCID 0000-0002-0320-512X
Jennette PrinceComputing and Data Science, Boston University, 665 Comm Ave, Boston, MA, 02215, USA.
Liangdong ZhouDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Xiuyuan Hugh WangDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Emily B TanziDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Mohammad KhalafiDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Sadek A NehmehDepartment of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA.
Silky Singh PahlajaniDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Hani HojjatiDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Lidia GlodzikDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Tracy ButlerDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Gloria C ChiangDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA.
Yi LiDepartment of Radiology, Brain Health Imaging Institute (BHII), Weill Cornell Medicine, New York, NY, 10065, USA. yil4008@med.cornell.edu.ORCID 0000-0002-3875-3513

Funding

NIA NIH HHS AG057848NIA NIH HHS AG077576
6 · The paper itself

Abstract

purpose[¹⁸F]MK-6240 is a widely used second-generation tau PET tracer in Alzheimer disease (AD) and is under FDA review, making it important to refine practical static imaging windows for clinical use. Prior dynamic studies have supported late static windows (~ 90-110 min) because they improve agreement between standard uptake value ratios (SUVR) and kinetic models in high-binding regions, but extracerebral skull and meningeal uptake becomes more prominent at later times and may confound visual interpretation and SUVR quantification. In this study, we aim to determine whether an earlier static window (40-60 min) provides comparable discrimination of tau burden while reducing extracerebral spill-in and SUVR instability.

methodsIn this retrospective within-subject study, 67 participants across the AD spectrum (normal controls (cognitively unimpaired) [NL], mild cognitive impairment [MCI], and AD) underwent [¹⁸F]MK-6240 PET with early (40-60 min) and late (90-120 min) frames. SUVRs were computed in the cerebral cortex (CTX) and Braak ROIs using cerebellar cortex as reference. Early-late agreement was assessed using correlation, regression, and Kolmogorov-Smirnov (KS) tests. Diagnostic and tau-status classification performance was evaluated with ROC analyses. Skull/meningeal uptake was graded visually and quantified, and PET-MRI misregistration simulations assessed SUVR robustness. Time-resolved analyses (30-120 min) evaluated temporal changes in stability and discrimination.

resultsEarly and late SUVRs were highly correlated (r ≥ 0.97; p < 0.01) and showed similar cohort-level distributions (CTX KS D = 0.060; p > 0.99). Discrimination was comparable for diagnosis and tau status (e.g., CTX AUC 0.88 vs. 0.85 for NL vs. MCI/AD). Late frames showed greater skull/meningeal uptake with increased spill-in and reference-region sensitivity; in tau-negative participants, skull SUVR exceeded entorhinal SUVR after ~ 60 min. Misregistration simulations showed greater variability for late versus early entorhinal SUVR (σ = 0.071 vs. 0.017). Time-resolved analyses showed that in this cohort, later acquisition did not materially improve diagnostic discrimination and was associated with more extracerebral contamination and instability.

conclusionThe 40-60-minute window provides discrimination comparable to 90-120 min while reducing extracerebral contamination and improving robustness, supporting shorter static [¹⁸F]MK-6240 protocols for clinical and research applications.

Indexed as

Alzheimer DiseaseIsoquinolinesPositron-Emission Tomographytau ProteinsAgedFemaleFluorine RadioisotopesHumansMaleRetrospective StudiesTime FactorsFluorine RadioisotopesIsoquinolinesMK-6240tau Proteins[18F]MK-6240Alzheimer diseaseOff-target bindingSUVRtau PET

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.